Nautilus Biotechnology Overview

  • Founded
  • 2016
Founded
  • Status
  • Public
  • Employees
  • 113
Employees
  • Stock Symbol
  • NAUT
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $3.66
  • (As of Monday Closing)

Nautilus Biotechnology General Information

Description

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.

Contact Information

Website
www.nautilus.bio
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Media and Information Services (B2B)
Discovery Tools (Healthcare)
Business/Productivity Software
Other Healthcare Technology Systems
Stock Exchange
NAS
Primary Office
  • 425 Pontius Avenue North
  • Suite 202
  • Seattle, WA 98109
  • United States
+1 (206) 000-0000

Nautilus Biotechnology Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nautilus Biotechnology Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.66 $3.50 $3.36 - $12.38 $435M 124M 404K -$0.60

Nautilus Biotechnology Financials Summary

In Thousands,
USD 		TTM 31-Dec-2021 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 299,444 299,444
Revenue 0 0 0
EBITDA (47,473) (47,473) (13,273)
Net Income (50,315) (50,315) (15,619)
Total Assets 398,450 398,450 85,011
Total Debt 30,032 30,032 4,775
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Nautilus Biotechnology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nautilus Biotechnology‘s full profile, request access.

Request a free trial

Nautilus Biotechnology Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore Nautilus Biotechnology‘s full profile, request access.

Request a free trial

Nautilus Biotechnology Patents

  • 36

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 7

    Pending

  • 000

    Expiring in next 12 mo

Nautilus Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020266136-A1 Methods and systems for integrated on-chip single-molecule detection Pending 29-Apr-2019 00000000000
US-20210239705-A1 Methods and applications of protein identification Pending 06-Jun-2018 00000000000
CA-3095762-A1 Methods of generating nanoarrays and microarrays Pending 04-Apr-2018 000000000
AU-2019247841-A1 Methods of generating nanoarrays and microarrays Pending 04-Apr-2018 000000000
EP-3775196-A1 Methods of generating nanoarrays and microarrays Pending 04-Apr-2018 C07K1/047
To view Nautilus Biotechnology’s complete patent history, request access »

Nautilus Biotechnology Executive Team (4)

Name Title Board Seat Contact Info
Sujal Patel Chief Executive Officer & Board Member
Anna Mowry Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Parag Mallick Ph.D Board Member & Executive
Nicholas Nelson Chief Business Officer
To view Nautilus Biotechnology’s complete executive team members history, request access »

Nautilus Biotechnology Board Members (9)

Name Representing Role Since
Farzad Nazem Self Board Member 000 0000
Matthew McIlwain Self Board Member 000 0000
Matthew Posard Self Chairman & Board Member 000 0000
Melissa Epperly Self Board Member 000 0000
Michael Altman Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Nautilus Biotechnology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nautilus Biotechnology Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Nautilus Biotechnology‘s full profile, request access.

Request a free trial

Nautilus Biotechnology Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 00000000 09-Jun-2021 0000000000 00000 Special Purpose Acquisition Company (SPAC)
To view Nautilus Biotechnology’s complete acquisitions history, request access »